D. Peest

2.0k total citations
42 papers, 925 citations indexed

About

D. Peest is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, D. Peest has authored 42 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 19 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in D. Peest's work include Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). D. Peest is often cited by papers focused on Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). D. Peest collaborates with scholars based in Germany, Sweden and France. D. Peest's co-authors include H. Deicher, D Pettersson, I. Schedel, Arnold Ganser, Anders Österborg, Hákan Mellstedt, G. Holm, Gerald Jäger, R Cimino and MA Boogaerts and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

D. Peest

41 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Peest Germany 17 585 319 270 243 180 42 925
M. A. Boogaerts Belgium 20 823 1.4× 242 0.8× 232 0.9× 266 1.1× 262 1.5× 29 1.2k
Paola Masolini Italy 17 389 0.7× 294 0.9× 157 0.6× 252 1.0× 187 1.0× 24 849
M Röper United States 8 291 0.5× 370 1.2× 598 2.2× 206 0.8× 159 0.9× 11 1.2k
P Resnitzky Israel 17 417 0.7× 121 0.4× 210 0.8× 274 1.1× 196 1.1× 61 974
C. Gattringer Austria 12 216 0.4× 408 1.3× 234 0.9× 342 1.4× 118 0.7× 45 939
RH van Oers Netherlands 11 317 0.5× 205 0.6× 404 1.5× 181 0.7× 149 0.8× 20 894
Jean Claude Brouet France 13 408 0.7× 221 0.7× 166 0.6× 389 1.6× 121 0.7× 16 836
Adriana Pleșa France 18 487 0.8× 311 1.0× 168 0.6× 464 1.9× 184 1.0× 79 1.1k
Gregory T. Stelzer United States 13 315 0.5× 102 0.3× 258 1.0× 231 1.0× 167 0.9× 28 843
XX Du United States 11 262 0.4× 297 0.9× 374 1.4× 194 0.8× 68 0.4× 18 790

Countries citing papers authored by D. Peest

Since Specialization
Citations

This map shows the geographic impact of D. Peest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Peest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Peest more than expected).

Fields of papers citing papers by D. Peest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Peest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Peest. The network helps show where D. Peest may publish in the future.

Co-authorship network of co-authors of D. Peest

This figure shows the co-authorship network connecting the top 25 collaborators of D. Peest. A scholar is included among the top collaborators of D. Peest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Peest. D. Peest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reuter, Sandra, D. Peest, Renata Stripecke, et al.. (2013). Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule. PLoS ONE. 8(12). e81360–e81360. 12 indexed citations
2.
Heuft, Hans‐Gert, et al.. (2013). Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation. Vox Sanguinis. 105(1). 18–27. 10 indexed citations
3.
Kittner, Jens M., et al.. (2007). Adult onset of T-cell deficiency with impaired CD2 expression complicated by Rhodococcus infection: a case report. Annals of Allergy Asthma & Immunology. 98(3). 294–298. 7 indexed citations
4.
Peest, D. & Arnold Ganser. (2007). Therapie des multiplen Myeloms. Der Internist. 48(12). 1343–1348. 1 indexed citations
5.
Engel, Holger, et al.. (2001). Multilokulärer Morbus Castleman vom gemischten Typ - Eine seltene Differenzialdiagnose bei Lymphadenopathie mit Schwäche, Gewichtsverlust und Nachtschweiß -. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1070–1072. 3 indexed citations
6.
Peest, D., et al.. (1996). CYTOKINE THERAPY IN MULTIPLE MYELOMA*. British Journal of Haematology. 94(3). 425–432. 13 indexed citations
9.
Peest, D.. (1996). [Multiple myeloma].. PubMed. 53(2). 147–51. 2 indexed citations
11.
Quesada, Silvia, Regine Leo, H. Deicher, & D. Peest. (1995). Functional and Biochemical Characteristics of a Soluble B Lymphocyte Proliferation-Inhibiting Activity Produced by Bone Marrow Cells from Multiple Myeloma Patients. Cellular Immunology. 162(2). 275–281. 3 indexed citations
12.
Link, Hartmut, Thomas Brune, G Hübner, et al.. (1993). Effect of recombinant human erythropoietin after allogeneic bone marrow transplantation. Annals of Hematology. 67(4). 169–173. 11 indexed citations
13.
Leo, R., Martin Boeker, D. Peest, et al.. (1992). Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells. Annals of Hematology. 64(3). 132–139. 92 indexed citations
14.
Peest, D., H. Deicher, R. Coldewey, et al.. (1990). Melphalan and Prednisone (MP) versus Vincristine, BCNU, Adriamycin, Melphalan and Dexamethasone (VBAMDex) Therapy for Multiple Myeloma. Oncology Research and Treatment. 13(1). 43–44.
15.
Peest, D., et al.. (1989). Effect of interleukin-2 on the ex vivo growth of human myeloma cells. Cancer Immunology Immunotherapy. 30(4). 227–232. 6 indexed citations
16.
Peest, D. & H. Deicher. (1988). Induktions- und Erhaltungstherapie beim multiplen Myelom. Oncology Research and Treatment. 11(1). 39–43. 1 indexed citations
17.
Peest, D., Hans‐Joachim Schmoll, I. Schedel, et al.. (1988). VBAMDex chemotherapy in advanced multiple myeloma*. European Journal Of Haematology. 40(3). 245–249. 4 indexed citations
18.
Peest, D., H. Deicher, R. Coldewey, Hans‐Joachim Schmoll, & I. Schedel. (1988). Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMP. European Journal of Cancer and Clinical Oncology. 24(6). 1061–1067. 31 indexed citations
19.
Peest, D., Björn Nashan, K Wonigeit, et al.. (1988). HIGH INCIDENCE OF MONOCLONAL IMMUNOGLOBULINS IN PATIENTS AFTER LIVER OR HEART TRANSPLANTATION. Transplantation. 46(3). 389–393. 28 indexed citations
20.
Peest, D., et al.. (1986). Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens.. PubMed. 65(1). 120–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026